CORDIS
EU research results

CORDIS

English EN

European Molecular Imaging Laboratories

Project information

Grant agreement ID: 503569

  • Start date

    1 July 2004

  • End date

    30 June 2009

Funded under:

FP6-LIFESCIHEALTH

  • Overall budget:

    € 29 400 000

  • EU contribution

    € 1 460

Coordinated by:

COMMISSARIAT À L'ENERGIE ATOMIQUE

France

Objective

The objective of EMIL is the creation of a Network of Excellence of European Molecular Imaging Laboratories for early stage diagnosis as well as therapeutic and prognosis assessment of cancer.
The general objectives of EMIL are:
(i) To coordinate the current effort in Molecular Imaging of Cancer in Europe by merging leading groups from universities, research centers and SMEs into ONE virtual excellence center;
(ii) To advance Molecular Imaging of Cancer to the scientific, technical and economical status that should be expected from its value for European citizens;
(iii) To act as a leverage for a strong technological development that can be fueled through specific research and development projects.
The Joint programme of activities is based on :
Integration activities :Sharing facilities and equipments : the Molecular Imaging Training Centers; Exchange and mobility of personnel; Integration of SMEs in the EMIL network
A joint programme of research activities with two dimensions for integration HORIZONTAL integration = tools for molecular imaging of cancer (Imaging technology; Imaging probes; Animal engineering) and VERTICAL integration = cancer imaging applications (Early diagnostic imaging; Followup of guided therapies; Imaging drug development).
Dissemination activities : Training.and Education; Communication; Management of common knowledge and Intellectual Property Rights.
EMIL will reach durable integration into the European Research Area through intellectual excellence, strong and durable cooperation with SMEs, Education activities, scientific management, and a research programme based on existing tools and ambitious objectives : assemble the critical mass necessary for international leadership, bridge gaps in the innovation system and raise health expectancies of the European population to the highest levels.

Coordinator

COMMISSARIAT À L'ENERGIE ATOMIQUE

Address

BÂTiment Le Ponant D, 25 Rue Leblanc
Paris

France

Participants (42)

UNIVERSITÀ DEGLI STUDI DI TORINO

Italy

KLINIKUM AT THE UNIVERSITY OF COLOGNE (MEDIZINISCHE EINRICHTUNGEN KOELN)

Germany

LEIDEN UNIVERSITY MEDICAL CENTER

Netherlands

UNIVERSITÀ DEGLI STUDI DI MILANO - CENTRO DI BIOTECNOLOGIE FARMACOLOGICHE

Italy

BIOSPACE MESURES

France

UNIVERSITEIT ANTWERPEN

Belgium

MAX-PLANCK-INSTITUTE FOR NEUROLOGICAL RESEARCH COLOGNE

Germany

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

France

INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE

France

UNIVERSITY OF COPENHAGEN, FACULTY OF HEALTH

Denmark

INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY, ACADEMY OF SCIENCES OF THE CZECH REPUBLIC

Czechia

INSTITUTE OF CARCINOGENESIS

Russia

UNIVERSITY OF MONS-HAINAUT

Belgium

UNIVERSITÉ HENRI POINCARÉ, NANCY 1

France

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE

Switzerland

NCPH-NATIONAL "FJC" RESEARCH INSTITUTE FOR RADIOBIOLOGY AND RADIOHYGIENE

Hungary

UNIVERSITY OF MAINZ

Germany

UNIVERSITÉ DE LIÈGE

Belgium

CENTRO DE NEUROCIÊNCIAS DE COIMBRA E BIOLOGIA CELULAR

Portugal

UNIVERSITY OF BASEL

Switzerland

CONSIGLIO NAZIONALE DELLE RICERCHE

Italy

UNIVERZITA KARLOVA - CHARLES UNIVERSITY, FACULTY OF SCIENCE

Czechia

DURHAM UNIVERSITY

United Kingdom

TECHNISCHE UNIVERSITEIT DELFT

Netherlands

UNIVERSITY OF DEBRECEN

Hungary

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

Germany

SKYSCAN

Belgium

MAUNA KEA TECHNOLOGIES

France

M R SOLUTIONS LTD

United Kingdom

THE VICTORIA UNIVERSITY OF MANCHESTER

United Kingdom

HOSPITAL CLINIC PROVINCIAL DE BARCELONA

Spain

JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG

Germany

STICHTING KATHOLIEKE UNIVERSITEIT, MORE PARTICULARLY: UNIVERSITY MEDICAL CENTRE NIJMEGEN

Netherlands

UNIVERSIDAD POLITÉCNICA DE MADRID

Spain

UNIVERSITY OF BERN

Switzerland

UNIVERSITY OF PISA, DIPARTIMENTO DI FISICA "E. FERMI"

Italy

FORSCHUNGSZENTRUM JUELICH GMBH

Germany

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

United Kingdom

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR

Italy

MEDRES MEDICAL RESEARCH GMBH IGR

Germany

DEPARTMENT OF NUCLEAR MEDICINE, TECHNICAL UNIVERSITY MUNICH

Germany

THE UNIVERSITY OF BIRMINGHAM

United Kingdom

Project information

Grant agreement ID: 503569

  • Start date

    1 July 2004

  • End date

    30 June 2009

Funded under:

FP6-LIFESCIHEALTH

  • Overall budget:

    € 29 400 000

  • EU contribution

    € 1 460

Coordinated by:

COMMISSARIAT À L'ENERGIE ATOMIQUE

France